FFL Partners, an American private equity firm, completed the investment in Apex Infusion, an ambulatory infusion therapy services provider. Financial terms were not disclosed. "We look forward to accelerating our growth in partnership with FFL. We have already begun mapping out areas to expand geographically through de novo locations, as well as strategic acquisitions to build scale,” Moussie Hailemariam, Apex Infusion CEO.